This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,858.76 for the supply of NEXPLANON 68 MG IMPLANTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not associated with any set-aside designation.
DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.
Generated 3/9/25, 12:48 AM